Remove news pharmaceutical
article thumbnail

#news #biotech Neurimmune expands drug discovery collaboration with Ono Pharmaceutical

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Neurimmune expands drug discovery collaboration with Ono Pharmaceutical. from European Biotechnology – first and foremost in European biotech [link].

Drugs 40
article thumbnail

#news #biotech Polyneuron Pharmaceuticals AG extends Series A financing

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Polyneuron Pharmaceuticals AG extends Series A financing. from European Biotechnology – first and foremost in European biotech [link].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

#news #biotech Bioinvent AB licences BI-1206 to CASI Pharmaceuticals

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bioinvent AB licences BI-1206 to CASI Pharmaceuticals. from European Biotechnology – first and foremost in European biotech [link].

article thumbnail

Magazine: CRISPR gene therapies cut through in 2023

Pharmaceutical Technology

Artificial intelligence (AI) continues to be in the news, and as pharma companies invest more to make sure they’re ahead of the game, international agencies have also started to catch up with regulations for AI-led healthcare research. You can also subscribe here to receive email notifications when a new issue is available.

article thumbnail

#news #biotech Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames.Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from … Continue reading →

article thumbnail

#news #biotech Chutes & Ladders—Proxy brawler Denner joins board at Ironwood Pharmaceuticals

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Proxy brawler Denner joins board at Ironwood Pharmaceuticals.Chutes & Ladders—Proxy brawler Denner joins board at Ironwood Pharmaceuticals kblankenship Thu, 11/12/2020 – 14:05 from FierceBiotech: (..)

article thumbnail

#news #biotech Eye disease biotech Orasis Pharmaceuticals nabs $30M for phase 3, sales activities

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eye disease biotech Orasis Pharmaceuticals nabs $30M for phase 3, sales activities.Eye disease biotech Orasis Pharmaceuticals nabs $30M for phase 3, sales activities badams Fri, 09/11/2020 – … Continue reading → (..)

Sales 40